MedRx Co., Ltd

¥38.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4586Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (22.74%)
Div yield —
ROE (49.61%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.55
PE TTM —
TSR TTM (70.08%)
Mkt cap ¥2.660B
ROIC (31.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥49
29.23%
(49.90%)
Hold 1|9|11|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.85
0.88
0.98
1.10
9.68%
6.29%
21.80%
24.32%
Revenue¥M
182.8
192.9
194.6
200.3
5.37%
14.42%
14.20%
12.15%
Peers (US$16.89M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.153
2.535
2.382
EBIT/Intx
2.293
0.192
0.251
Own earn%
111.85
(90.88)
(70.35)
Sh yield%
51.40
3.34
3.09
Owners
Insiders/Inst%
12.90
81.34
Short interest%
3.66
SBC / revenue%
3.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
5–12
$1 testx
—
Incr. ROIC%
0